Hyperlipidemia and hypertension: impact of steroid withdrawal.
Van Buren
C T
CT
University of Texas Medical School, Division of Immunology and Organ Transplantation, Houston 77030.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use; D016027:Heart Transplantation / Q000009:adverse effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000178:diet therapy / Q000188:drug therapy; D006973:Hypertension / Q000139:chemically induced*; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D011183:Postoperative Complications; D013375:Substance Withdrawal Syndrome
D000305:Adrenal Cortex Hormones; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002792:Cholestyramine Resin; D015248:Gemfibrozil